200 results on '"Laar, Jan A. M."'
Search Results
2. Real-world experience with targeted therapy in patients with histiocytic neoplasms in the Netherlands and in Belgium
3. Novel RAB27A Variant Associated with Late-Onset Hemophagocytic Lymphohistiocytosis Alters Effector Protein Binding
4. Clinicogenomic associations in childhood Langerhans cell histiocytosis: an international cohort study
5. Aggressive unifocal bone Langerhans cell histiocytosis with soft tissue extension both responsive to radiotherapy: a case report
6. Hemophagocytic Lymphohistiocytosis in Activated PI3K Delta Syndrome: an Illustrative Case Report
7. BRAF V600E is associated with higher incidence of second cancers in adults with Langerhans cell histiocytosis
8. Consensus-Based Guidelines for the Recognition, Diagnosis, and Management of Hemophagocytic Lymphohistiocytosis in Critically Ill Children and Adults
9. Correction to: Hemophagocytic lymphohistiocytosis in activated PI3K delta syndrome, an illustrative case report
10. Long-Term Follow-Up of Patients with Scleritis After Rituximab Treatment Including B Cell Monitoring
11. Digital Outcome Measurement to Improve Care for Patients With Immune-Mediated Inflammatory Diseases: Protocol for the IMID Registry
12. BRAFV600Eis associated with higher incidence of second cancers in adults with Langerhans cell histiocytosis
13. Additional file 1 of The role of etoposide in the treatment of adult patients with hemophagocytic lymphohistiocytosis
14. Extensive, circumferential, epidural spinal cord compression by IgG4-related pachymeningitis.
15. BRAFV600E is associated with higher incidence of second cancers in adults with Langerhans cell histiocytosis
16. Implications of Elevated C‐Reactive Protein and Serum Amyloid A Levels in IgG4‐Related Disease: Comment on the Article by Perugino et al
17. To distinguish IgG4-related disease from seronegative granulomatosis with polyangiitis
18. Decreased quality of life and societal impact of cryopyrin-associated periodic syndrome treated with canakinumab: a questionnaire based cohort study
19. Bone Mineral Density in Sjögren Syndrome Patients with and Without Distal Renal Tubular Acidosis
20. Cytokine and viral load kinetics in human herpesvirus 8-associated multicentric Castleman’s disease complicated by hemophagocytic lymphohistiocytosis
21. Chronic signs of memory B cell activation in patients with Behçet’s disease are partially restored by anti-tumour necrosis factor treatment
22. A pilot study into bosentan (Tracleer®) as an immunomodulating agent in patients with Behçet’s disease.
23. Serum CCL17 distinguishes sarcoid uveitis from TB ‐uveitis and QFT ‐negative uveitis
24. ALK-positive histiocytosis: a new clinicopathologic spectrum highlighting neurologic involvement and responses to ALK inhibition
25. Everything you need to know about distal renal tubular acidosis in autoimmune disease
26. Comparison of 5-Fluoro-2’-Deoxyuridine and 5-Fluorouracil in the Treatment of Murine Colon Cancer; Effects on Thymidylate Synthase
27. Comparison of Continuous Infusions and Bolus Injections of 5.Fluorouracil with or without Leucovorin: Implications for Inhibition of Thymidylate Synthase
28. Efficacy and maintenance of rituximab treatment in non‐infectious scleritis
29. Prevalence of distal renal tubular acidosis in primary Sjögrenʼs syndrome
30. Human Tbk1 Deficiency Leads To Autoinflammation Driven By Tnf-Induced Cell Death
31. Consensus-Based Guidelines for the Recognition, Diagnosis, and Management of Hemophagocytic Lymphohistiocytosis in Critically Ill Children and Adults.
32. Parafoveal Microvascular Alterations in Ocular and Non-Ocular Behҫet's Disease Evaluated With Optical Coherence Tomography Angiography
33. Leukocyte toll-like receptor expression in pathergy positive and negative Behçet’s disease patients
34. Persistent Laryngeal Swelling Caused by Primary Intralymphatic Histiocytosis
35. Behçet's Disease Under Microbiotic Surveillance? A Combined Analysis of Two Cohorts of Behçet's Disease Patients
36. Apparent Lack of BRAFV600E Derived HLA Class I Presented Neoantigens Hampers Neoplastic Cell Targeting by CD8+ T Cells in Langerhans Cell Histiocytosis
37. Sensitivity and specificity of serum soluble interleukin-2 receptor for diagnosing sarcoidosis in a population of patients suspected of sarcoidosis
38. A rare infection in the tropics that is not uncommon in cases of chronic granulomatous disease
39. Low prevalence of NOD2 SNPs in Behçetʼs disease suggests protective association in Caucasians
40. Efficacy and maintenance of rituximab treatment in non‐infectious scleritis.
41. Epstein-Barr Viral Load Assessment in Immunocompetent Patients With Fulminant Infectious Mononucleosis
42. Diagnosis and treatment of uveitis; not restricted to the ophthalmologist
43. Comparison of 5-Fluoro-2’-Deoxyuridine and 5-Fluorouracil in the Treatment of Murine Colon Cancer; Effects on Thymidylate Synthase
44. Recommendations for the management of hemophagocytic lymphohistiocytosis in adults
45. MxA is a clinically applicable biomarker for type I interferon activation in systemic lupus erythematosus and systemic sclerosis
46. The treatment outcomes in IgG4‐related orbital disease: a systematic review of the literature
47. Leukocyte toll-like receptor expression in pathergy positive and negative Behçet's disease patients.
48. Infliximab treatment in pathology-confirmed neurosarcoidosis.
49. Can epidemiological studies uncover the origin of Behçet’s disease?
50. Chest Radiographic Screening for Sarcoidosis in the Diagnosis of Patients with Active Uveitis
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.